Green Cross (005250)

Currency in KRW
15,190
-1,180(-7.21%)
Closed·
Unusual trading volume
005250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15,12015,770
52 wk Range
12,94018,010
Key Statistics
Bid/Ask
15,190.00 / 15,210.00
Prev. Close
16,370
Open
15,580
Day's Range
15,120-15,770
52 wk Range
12,940-18,010
Volume
704.07K
Average Volume (3m)
292.22K
1-Year Change
10.1523%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
005250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
18/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1,531.09%
Dividend Yield
1.83%
Industry Median 0.99%
Annualised payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 005250 to Peers and Sector

Metrics to compare
005250
Peers
Sector
Relationship
P/E Ratio
−10.8x11.9x−0.5x
PEG Ratio
0.03−0.360.00
Price/Book
0.8x1.8x2.6x
Price / LTM Sales
0.3x6.4x3.1x
Upside (Analyst Target)
-39.7%54.0%
Fair Value Upside
Unlock19.6%6.5%Unlock

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.

Employees
144

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.85M6.28%46.68B
Other Institutional Investors
12.73M28.04%208.41B
Public Companies & Retail Investors
29.82M65.68%488.14B
Total
45.4M100.00%743.23B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MOGAM Biotechnology Research Institute9.04%4,102,19067,152,850
National Pension Service6.15%2,791,54945,697,657

People Also Watch

17,220
069260
-0.35%
15,220
300720
+1.47%
64,600
001430
+6.43%
44,300
007340
-0.56%
11,560
114090
+0.52%

FAQ

What Is the Green Cross (Seoul: 005250) Share Price Today?

The Green Cross stock price today is 15,190 KRW.

What Stock Exchange Does Green Cross (005250) Trade On?

Green Cross is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Green Cross?

The stock symbol (also called a 'ticker') for Green Cross is "005250."

Does Green Cross Pay Dividends? What’s The Current 005250 Dividend Yield?

Yes, 005250 Pays Dividends to its Shareholders. The current Green Cross dividend yield is 1.97%.

What Is the Current Green Cross Market Capitalisation?

As of today, Green Cross (Seoul: 005250) market cap is 692.05B KRW.

What Is Green Cross's (005250) Earnings Per Share (TTM)?

The Green Cross EPS is currently -1,531 (Trailing Twelve Months).

When Is the Next Green Cross Earnings Date?

Green Cross's next earnings report will be released on 18/08/2026.

Is 005250 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Green Cross moving averages and other technical indicators, the daily buy/sell signal for 005250 stock is Buy.

How Many Times Has Green Cross Stock Split?

Green Cross has split 9 times. (See the 005250 stock split history page for full effective split date and price information.)

How Many Employees Does Green Cross Have?

Green Cross has 144 employees, based on their latest Companies House report.

What is the current trading status of Green Cross (Seoul: 005250)?

As of 21/05/2026, Green Cross (005250) is trading at a share price of 15,190 KRW, with a previous close of 16,370 KRW. The stock has fluctuated within a day range of 15,120 KRW to 15,770 KRW, while its 52-week range spans from 12,940 KRW to 18,010 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.